By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

American Neurological Association 

15000 Commerce Parkway
Suite C
Mount Laurel  New Jersey  08054  U.S.A.
Phone: 856-638-0423 Fax: 856-439-0525


SEARCH JOBS


Industry
Services






Company News
AVANIR Pharmaceuticals (AVNR) Announces Data Presentations At The American Neurological Association's (ANA) 2014 Annual Meeting Including Results From The Phase 2 Trial For Treatment Of Agitation In Patients With Alzheimer's Disease 10/8/2014 8:36:43 AM
Catalyst Pharmaceutical Partners, Inc. (CPRX) To Present Top-Line Safety And Efficacy Results From Phase 3 Firdapse Trial At 139th Annual Meeting Of The American Neurological Association 10/8/2014 7:19:36 AM
Intra-Cellular Therapies, Inc. To Present Results From Phase 1/2 Clinical Trial For ITI-007 In Healthy Geriatric Subjects And Patients With Dementia At The American Neurological Association 139th Annual Meeting 10/7/2014 7:24:39 AM
Upsher-Smith Laboratories Reports Favorable Results From Phase 1 Clinical Trial of USL255 (Extended-Release Topiramate) at American Neurological Association's 2013 Annual Meeting 10/15/2013 10:36:26 AM
Acorda Therapeutics (ACOR) Shows Off Positive Dalfampridine-ER Data in Post-Stroke Deficits at American Neurological Association 2013 Annual Meeting 10/14/2013 6:37:08 AM
NeuralStem Inc. Release: Dr. Eva Feldman, Principal Investigator, to Give Update on ALS Trial at American Neurological Association Meeting 10/10/2013 8:17:21 AM
International Stem Cell Corporation to Present New Data From Parkinson's Disease Program at the American Neurological Association 2013 Annual Meeting 9/25/2013 9:21:42 AM
Alexion Pharmaceuticals Inc. (ALXN) Release: Data From Investigator-Initiated Phase 2 Study of Eculizumab (Soliris®) in Patients With Severe Relapsing Neuromyelitis Optica (NMO) Presented at the American Neurological Association Annual Meeting 10/9/2012 9:39:04 AM
AVANIR Pharmaceuticals (AVNR) Presents Detailed Zenvia Confirmatory Phase III Results in Late-Breaker Session at American Neurological Association Meeting 10/13/2009 11:46:41 AM
AVANIR Pharmaceuticals (AVNR) to Present Pivotal Zenvia Phase III Data at American Neurological Association and World Congress on Controversies in Neurology Annual Meetings 10/6/2009 8:14:12 AM
12
//-->